Axcynsis Therapeutics Pte. Ltd. is a platform-based biotechnology company focusing on the development of Antibody-X Conjugate (AXC) therapies to revolutionize cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options.
Social Link - Linkedin: http://www.linkedin.com/company/axcynsis-therapeutics
Employee Count: 50
Keywords: biotechnology research